The Most Recent Biotech IPOs To Keep An Eye On
Biotech IPOs have helped drug developers raise over $5 billion so far this year.
Insider Trading: The Most-Bought Mid-Caps Amid The Pandemic
Top five mid-cap companies that have been experiencing insider buying amid the coronavirus crisis.
With Gains Of 2300% Or More, Which Of These Best-Performing Coronavirus Stocks Are Buys?
With year-to-date gains of 2300%, 3300% and 3400%, respectively, the three stocks that are the focus of today’s article – two biotechs and a molecular… Read More »With Gains Of 2300% Or More, Which Of These Best-Performing Coronavirus Stocks Are Buys?
10 Under $10: “Cheap Stocks With Rich Paths Ahead”
When it comes to cheap stocks, the author of today’s article notes that “beyond the risks there is potential for big reward.” As such, she… Read More »10 Under $10: “Cheap Stocks With Rich Paths Ahead”
3 “Strong Buy” Pharma Stocks With Significant Upside Potential – And Catalysts Around The Corner
Regarding investor behavior amid the current market volatility, the author of today’s article observes that “A select group remains ready to take on some risk,… Read More »3 “Strong Buy” Pharma Stocks With Significant Upside Potential – And Catalysts Around The Corner
The Right Stocks Right Now: 3 Penny Stocks With “Strong Buy” Ratings And “Massive Upside Potential”
“We’re not in a true bull market – not by a long shot – but the recent bear has pushed prices down and the current… Read More »The Right Stocks Right Now: 3 Penny Stocks With “Strong Buy” Ratings And “Massive Upside Potential”
Following The Insiders Towards Returns
Restrictions put in place to help reduce the spread of COVID-19 are beginning to be eased in the U.S. and many other countries. At the… Read More »Following The Insiders Towards Returns
Remdesivir’s COVID-19 Success Could Create A Big “Piggyback” Opportunity For This Under-The-Radar Biotech
There is currently only one drug that has demonstrated the potential to be a safe and effective treatment for COVID-19 in clinical trials: Gilead Sciences’… Read More »Remdesivir’s COVID-19 Success Could Create A Big “Piggyback” Opportunity For This Under-The-Radar Biotech
Top Biotech Stocks For May – Including A High-Risk/High-Reward Play
When it comes to the top biotech stocks to consider buying this month, as identified in today’s article, one has a virtual monopoly in its… Read More »Top Biotech Stocks For May – Including A High-Risk/High-Reward Play
The Massive – And Mysterious – Rally Of The World’s Best-Performing Stock
What’s clear is that, having surged 2,819% in the past 12 months (and 351% so far this year in the face of a market meltdown),… Read More »The Massive – And Mysterious – Rally Of The World’s Best-Performing Stock